Solution Structure of the DNA Binding Domain of HIV-1 Integrase
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The solution structure of the DNA binding domain of HIV-1 integrase (residues 220-270) has been determined by multidimensional NMR spectroscopy. The protein is a dimer in solution, and each subunit is composed of a five-stranded beta-barrel with a topology very similar to that of the SH3 domain. The dimer is formed by a stacked beta-interface comprising strands 2, 3, and 4, with the two triple-stranded antiparallel beta-sheets, one from each subunit, oriented antiparallel to each other. One surface of the dimer, bounded by the loop between strands beta 1 and beta 2, forms a saddle-shaped groove with dimensions of approximately 24 x 23 x 12 A in cross section. Lys264, which has been shown from mutational data to be involved in DNA binding, protrudes from this surface, implicating the saddle-shaped groove as the potential DNA binding site.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The expansion of the intasome architecture in these viruses is dictated by three factors.”
From Structure and function of retroviral integrase (2022) · cites this paper as [44]
Citations
Cites
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581 · cited 1×
“Eighty-two percent of the residues lie within the most favored region of the Ramachandran $,q plot, 16% in the additionally allowed regions, and 2% in the generously allowed regions (Laskowski et al., 1993).”
BackgroundCHARMM: A program for macromolecular energy, minimization, and dynamics calculations
Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., & Karplus, M. (1983) · Journal of Computational Chemistry · doi:10.1002/jcc.540040211 · Cited by 14,944
Solvation energy in protein folding and binding
Eisenberg, D., & McLachlan, A. D. (1986) · Nature · doi:10.1038/319199a0 · Cited by 1,863
Dyda, F., Hickman, A. B., Jenkins, T. M., Engelman, A., Craigie, R., & Davies, D. R. (1994) · Science · doi:10.1126/science.7801124 · Cited by 810 · cited 1×
“The catalytic domain is also dimeric with the two subunits oriented parallel to each other (Dyda et al., 1994).”
BackgroundSelf-citationNilges, M., Clore, G. M., & Gronenborn, A. M. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)81148-7 · Cited by 770 · cited 1×
“The structures were calculated using a modified version of the hybrid distance geometry-dynamical simulated annealing protocol (Nilges et al., 1988 square-well quadratic potentials for the experimental distance and torsion angle restraints, and a quartic van der Waals repulsion term for the…”
MethodSelf-citationProtein Design by Binary Patterning of Polar and Nonpolar Amino Acids
Kamtekar, S., Schiffer, J. M., Xiong, H., Babik, J. M., & Hecht, M. H. (1993) · Science · doi:10.1126/science.8259512 · Cited by 730
Protein-protein interactions: A review of protein dimer structures
Jones, S., & Thornton, J. M. (1995) · Progress in Biophysics and Molecular Biology · doi:10.1016/0079-6107(94)00008-w · Cited by 562
Binding and Stimulation of HIV-1 Integrase by a Human Homolog of Yeast Transcription Factor SNF5
Kalpana, G. V., Marmon, S., Wang, W., Crabtree, G. R., & Goff, S. P. (1994) · Science · doi:10.1126/science.7801128 · Cited by 530 · cited 1×
“The Val260 -Glu mutation affects multimeric interactions in intact integrase (Kalpana et al., 1994).”
BackgroundStructure of papain refined at 1.65 Å resolution
Kamphuis, I. G., Kalk, K. H., Swarte, M. B. A., & Drenth, J. (1984) · Journal of Molecular Biology · doi:10.1016/0022-2836(84)90467-4 · Cited by 518 · cited 1×
“These include the . carboxy-terminal domains of papain (Kamphuis et al., 1984) and the BirA repressor (Wilson et al., 1992), type I1 plasmid-encoded R67 dihydrofolate reductase (Matthews et al., 1986), the PsaE polypeptide from photosystem I of cyanobacteria (Falzone et al., 1994), and the small…”
BackgroundRibbon models of macromolecules
Carson, M. (1987) · Journal of Molecular Graphics · doi:10.1016/0263-7855(87)80010-3 · Cited by 516 · cited 2×
“The figure was generated with the program RIBBONS (Carson, 1987).”
Method
Cited by
Items 101–200 of 304
Tekeste, S. S., Wilkinson, T. A., Weiner, E. M., Xu, X., Miller, J. T., Le Grice, S. F. J., Clubb, R. T., & Chow, S. A. (2015) · Journal of Virology · doi:10.1128/jvi.01471-15 · Cited by 51
Current Developments in HIV Chemotherapy
Meadows, D. C., & Gervay‐Hague, J. (2005) · ChemMedChem · doi:10.1002/cmdc.200500026 · Cited by 59
Zhao, Z., McKee, C. J., Kessl, J. J., Santos, W. L., Daigle, J. E., Engelman, A., Verdine, G., & Kvaratskhelia, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705241200 · Cited by 49
Self-citationvan den Ent, F. M. I., Vos, A., & Plasterk, R. H. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3176-3183.1999 · Cited by 49
“It binds DNA nonspecifically (24, 37, 52, 68, 74), and its structure is similar to that of Src homology 3 (SH3) domains (17, 44).”
BackgroundStructure-based HIV-1 integrase inhibitor design: a future perspective
Neamati, N. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.2.281 · Cited by 60
Sluis‐Cremer, N., & Tachedjian, G. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03216.x · Cited by 49
Lloréns, C., Fares, M. A., & Moyá, A. (2008) · BMC Evolutionary Biology · doi:10.1186/1471-2148-8-276 · Cited by 53
“The traditional core used for inferring INT phylogenies is common to all INTs in general, and includes 2 of these sub-domains; the conserved zinc finger "HHCC" binding motif [38] at the N-terminus, and the central sub-domain containing the conserved D-D-E trait [39,40].”
Method2 Molecular genetics and target site specificity of retroviral integration
Holmes-Son, M. L., Appa, R. S., & Chow, S. A. (2001) · Advances in genetics · doi:10.1016/s0065-2660(01)43003-3 · Cited by 57
A Homology Model of HIV-1 Integrase and Analysis of Mutations Designed to Test the Model
Johnson, B. C., Métifiot, M., Ferris, A. L., Pommier, Y. G., & Hughes, S. H. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.03.027 · Cited by 52
HIV-1 Integrase Multimerization as a Therapeutic Target
Feng, L., Larue, R. C., Slaughter, A., Kessl, J. J., & Kvaratskhelia, M. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_439 · Cited by 62
“NMR structures of IN NTD (1–47) (Cai et al. 1997) and a C-terminally truncation IN CTD (220–270) (Lodi et al. 1995; Eijkelenboom et al. 1995, 1999) revealed dimeric organizations for each of the domains.”
BackgroundBrigo, A., Lee, K. W., Mustata, G. I., & Briggs, J. M. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.050286 · Cited by 48
“The solution structures of the isolated N-terminal and C-terminal domains have been determined by NMR (Cai et al., 1997; Eijkelenboom et al., 1997, 1995; Lodi et al., 1995).”
MethodMohammed, K. D., Topper, M. B., & Muesing, M. A. (2011) · Journal of Virology · doi:10.1128/jvi.02374-10 · Cited by 44
Johnson, B. C., Métifiot, M., Pommier, Y. G., & Hughes, S. H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05292-11 · Cited by 48
“Individual domains have been solved by nuclear magnetic resonance (NMR) (8, 9, 18, 40) and crystallography (6, 12, 13, 17, 18, 24–26, 44, 55), but these partial structures provided little insight into the overall architecture of the intasome.”
BackgroundDelbrück, H., Ziegelin, G., Lanka, E., & Heinemann, U. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110103200 · Cited by 45
Shkriabai, N., Patil, S. S., Hess, S. Y., Budihas, S. R., Craigie, R., Burke, T. R., Grice, S. F. J. L., & Kvaratskhelia, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400873101 · Cited by 50
Self-citationFunctional evolution of two subtly different (similar) folds
Agrawal, V., & Kishan, K. V. R. (2001) · BMC Structural Biology · doi:10.1186/1472-6807-1-5 · Cited by 42
“It was suggested by Lodi et al[22] that SH3-fold was suitable to graft many different binding properties.”
BackgroundCai, M., Caffrey, M. S., Clore, G. M., Gronenborn, A. M., Huang, Y. K., Zheng, R., & Craigie, R. (1998) · Protein Science · doi:10.1002/pro.5560071221 · Cited by 42
“HIV integrase comprises three functional and structural domains whose structures have been solved: a central catalytic core (Dyda et al., 1994), an N-terminal zinc binding domain (Cai et al., 1997; Eijkelenboom et al., 1997) and a C-terminal DNA binding domain (Eijkelenboom et al., 1995: Lodi et al., 1995 ).”
BackgroundSelf-citationFrom structure to chemical shift and vice-versa
Hunter, C. A., Packer, M. J., & Zonta, C. (2005) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2005.06.001 · Cited by 42
Recent Advances in the Discovery of Small-Molecule Inhibitors of HIV-1 Integrase
Choi, E., Mallareddy, J. R., Lu, D., & Kolluru, S. (2018) · Future Science OA · doi:10.4155/fsoa-2018-0060 · Cited by 51
Wielens, J., Headey, S. J., Jeevarajah, D., Rhodes, D. I., Deadman, J. J., Chalmers, D. K., Scanlon, M. J., & Parker, M. W. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.03.016 · Cited by 46
Brigo, A., Lee, K. W., Fogolari, F., Mustata, G. I., & Briggs, J. M. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20447 · Cited by 44
Liu, W. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1501 · Cited by 41
HIV-I integrase inhibitors: Past, present, and future
Neamati, N., Marchand, C., & Pommier, Y. G. (2000) · Advances in pharmacology · doi:10.1016/s1054-3589(00)49026-5 · Cited by 48
Peptides that inhibit HIV‐1 integrase by blocking its protein–protein interactions
Maes, M., Loyter, A., & Friedler, A. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08680.x · Cited by 145
Molecular docking, QPLD, and ADME prediction studies on HIV-1 integrase leads
Tripathi, S. K., Selvaraj, C., Singh, S. K., & Reddy, K. K. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9940-6 · Cited by 44
“catalytic domain of IN was determined by X-ray crystallography (Lodi et al., 1995; Cai et al., 1997; Eijkelenboom et al., 1995; Dyda et al., 1994; Bujacz et al., 1995).”
MethodSpeck‐Planche, A., Kleandrova, V. V., Luan, F., & Cordeiro, M. N. D. S. (2012) · Molecular BioSystems · doi:10.1039/c2mb25093d · Cited by 40
Kirchner, J., & Sandmeyer, S. B. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4737-4747.1996 · Cited by 41
“A nuclear magnetic resonance solution structure of the carboxyl-terminal dimer region has been determined recently; it contains a groove within which the substrate DNA could potentially rest (24, 56).”
BackgroundBiochemical and virological analysis of the 18-residue C-terminal tail of HIV-1 integrase
Dar, M. J., Monel, B., Krishnan, L., Shun, M.-C., Di Nunzio, F., Helland, D. E., & Engelman, A. (2009) · Retrovirology · doi:10.1186/1742-4690-6-94 · Cited by 38
“GKQMAGDDSMAGGQDESQGLE -2 …WKGPGELLWKGEGAVLVKVGTDIKIIPRRKAKIIRDYGGRQEMDSGSHLEGAREDGEMA 23 5 24 0 25 0 26 0 26 6 27 0 27 3 27 6 27 9 28 2 28 5 28 8 64 CTDNTD 288 43401612 116 235 159152 CCD HH CC D D K WEHIV-1 IN 2 3 4 5 HIV-1 SIVcpz HIV-2 Page 5 of 13 (page number not for citation purposes) To follow the course of the…”
InfluentialSelf-citationHIV-1 Integrase: From Biology to Chemotherapeutics
Loizidou, E. Z., Nicolaou, C. A., Nicolaides, A. V., & Kostrikis, L. G. (2007) · Current HIV Research · doi:10.2174/157016207781023965 · Cited by 43
Katzman, M., & Sudol, M. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.1744-1753.1998 · Cited by 41
“For example, multidimensional nuclear magnetic resonance spectroscopy indicates that the C-terminal regions dimerize in an antiparallel orientation (48), and competition studies using a panel of monoclonal antibodies against various parts of HIV-1 IN suggest that the C terminus is in close proximity to both the centra…”
BackgroundProtein–protein interactions probed by nuclear magnetic resonance spectroscopy
Qin, J., Vinogradova, O., & Gronenborn, A. M. (2001) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(01)39323-0 · Cited by 37
Self-citationHiv integrase: a target for aids therapeutics
Thomas, M., & Brady, L. (1997) · Trends in biotechnology · doi:10.1016/s0167-7799(97)01016-0 · Cited by 39
Molecular dynamics studies of the full-length integrase–DNA complex
Luca, L. D., Vistoli, G., Pedretti, A., Barreca, M. L., & Chimirri, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.211 · Cited by 42
Multimodal Functionalities of HIV-1 Integrase
Engelman, A., & Kvaratskhelia, M. (2022) · Viruses · doi:10.3390/v14050926 · Cited by 41
“The CCD is a homodimer wherein each monomer adopts an RNase H fold [80] and the CTD adopts a beta-stranded SH3 fold [81,82].”
BackgroundSelf-citationMapping DNA‐binding sites of HIV‐1 integrase by protein footprinting
Dirac, A. M. G., & Kjems, J. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01932.x · Cited by 34
Retroviral cDNA Integration: Mechanism, Applications and Inhibition
Hansen, M. S. T., Carteau, S., Hoffmann, C. J., Li, L., & Bushman, F. D. (1998) · Springer eBooks · doi:10.1007/978-1-4899-1739-3_3 · Cited by 37
Wlodawer, A. (1999) · Advances in virus research · doi:10.1016/s0065-3527(08)60305-x · Cited by 40
Mutations in Nonconserved Domains of Ty3 Integrase Affect Multiple Stages of the Ty3 Life Cycle
Nymark-McMahon, M. H., & Sandmeyer, S. B. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.453-465.1999 · Cited by 33
“The carboxyl-terminal domain of several retroviral IN proteins has been shown to mediate nonspecific DNA binding (22, 43, 57, 64, 66, 76, 79, 83, 84).”
BackgroundHIV-1 integrase interacts with yeast microtubule-associated proteins
de Soultrait, V. R., Caumont‐Sarcos, A., Durrens, P., Calmels, C., Parissi, V., Recordon-Pinson, P., Bon, E., Desjobert, C., Tarrago‐Litvak, L., & Fournier, M. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00241-5 · Cited by 31
Shkriabai, N., Dharmarajan, V., Slaughter, A., Kessl, J. J., Larue, R. C., Feng, L., Fuchs, J. R., Griffin, P. R., & Kvaratskhelia, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.589572 · Cited by 30
In Search of Authentic Inhibitors of HIV-1 Integration
Debyser, Z., Cherepanov, P., Maele, B. V., Clercq, E. D., & Witvrouw, M. (2002) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020201300101 · Cited by 31
“The C-terminal domain (residues 220–270) binds non-specifically to DNA and forms a dimer of parallel monomers, as shown by NMR (Eijkelenboom et al., 1995; Lodi et al., 1995).”
BackgroundInfluentialKitamura, Y., Ishikawa, T., Okui, N., Kobayashi, N., Kanda, T., Shimada, T., Miyake, K., & Yoshiike, K. (1999) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199902010-00001 · Cited by 35
Refined solution structure of the dimeric N-terminal HHCC domain of HIV-2 integrase
Eijkelenboom, A. P. A. M., van den Ent, F. M. I., Wechselberger, R. W., Plasterk, R. H. A., Kaptein, R., & Boelens, R. (2000) · Journal of Biomolecular NMR · doi:10.1023/a:1008342312269 · Cited by 29
“The structure of the C-terminal DNA-binding domain has been determined by NMR spectroscopy (Eijkelenboom et al., 1995, 1999; Lodi et al., 1995).”
MethodBojja, R. S., Andrake, M. D., Weigand, S., Merkel, G., Yarychkivska, O., Henderson, A., Kummerling, M., & Skalka, A. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.212571 · Cited by 29
Taddeo, B., Carlini, F., Verani, P., & Engelman, A. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8277-8284.1996 · Cited by 29
“The carboxyl-terminal domain, which is a dimer in solution (18, 43), also contributes to the multimerization of HIV-1 integrase (30).”
BackgroundSelf-citationMutational Analysis of the Mu Transposase
Krementsova, E. B., Giffin, M. J., Pincus, D., & Baker, T. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31358 · Cited by 29
Advances in the development of HIV integrase strand transfer inhibitors
Wang, Y., Gu, S., He, Q., & Fan, R. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113787 · Cited by 29
Retroviral Integrase: Then and Now
Andrake, M., & Skalka, A. M. (2015) · Annual Review of Virology · doi:10.1146/annurev-virology-100114-055043 · Cited by 38
Maroun, R. G., Krebs, D., Roshani, M., Porumb, H., Auclair, C., Troalen, F., & Fermandjian, S. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00130.x · Cited by 31
Barsov, E. V., Huber, W., Marcotrigiano, J., Clark, P. K., Clark, A. D., Arnold, E., & Hughes, S. H. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4484-4494.1996 · Cited by 30
“Crystal structures of the catalytic cores of HIV-1 (15) and Rous sarcoma virus (6) INs and a nuclear magnetic resonance spectroscopy-based structure of the C-terminal domain (34) have recently been reported.”
BackgroundZhao, Y., Li, W., Zeng, J., Liu, G., & Tang, Y. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21955 · Cited by 29
Williams, K. L., Zhang, Y., Shkriabai, N., Karki, R. G., Nicklaus, M. C., Kotrikadze, N., Hess, S. Y., Grice, S. F. J. L., Craigie, R., Pathak, V. K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m413579200 · Cited by 30
Self-citationYi, J., Arthur, J. W., Dunbrack, R. L., & Skalka, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005499200 · Cited by 27
Isolation and Characterization of an Oligomerization-Negative Mutant of HIV-1 Integrase
Kalpana, G. V., Reicin, A. S., Cheng, G., Sorin, M., Paik, S., & Goff, S. P. (1999) · Virology · doi:10.1006/viro.1999.9767 · Cited by 36
Integron-sequestered dihydrofolate reductase: a recently redeployed enzyme
Alonso, H., & Gready, J. E. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.03.003 · Cited by 26
Lins, R. D., Adesokan, A. A., Soares, T. A., & Briggs, J. M. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00059-5 · Cited by 28
Structural and sequencing analysis of local target DNA recognition by MLV integrase
Aiyer, S., Rossi, P., Malani, N., Schneider, W. M., Chandar, A., Bushman, F. D., Montelione, G. T., & Roth, M. J. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv410 · Cited by 25
HIV-1 Integrase Inhibitors: A Review of Their Chemical Development
Ingale, K. B., & Bhatia, M. S. (2011) · Antiviral chemistry & chemotherapy · doi:10.3851/imp1740 · Cited by 32
“The N-terminal domain involved in multimerization contains two His and two Cys residues involved in zinc coordination by this domain [13,14].”
BackgroundHIV-1 Integrase-DNA Recognition Mechanisms
Kessl, J. J., McKee, C. J., Eidahl, J. O., Shkriabai, N., Katz, A., & Kvaratskhelia, M. (2009) · Viruses · doi:10.3390/v1030713 · Cited by 30
“Results of structural biology studies revealed each individual domain as a dimer [35–39].”
BackgroundMutational Scan of the Human Immunodeficiency Virus Type 2 Integrase Protein
van den Ent, F. M. I., Vos, A., & Plasterk, R. H. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.3916-3924.1998 · Cited by 25
“structure revealed that it has a Src homology 3-like fold (13, 29).”
BackgroundZargarian, L., Benleulmi, M. S., Renisio, J., Merad, H., Maroun, R. G., Wieber, F., Mauffret, O., Porumb, H., Troalen, F., & Fermandjian, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211711200 · Cited by 27
The Effect of Treatment-Associated Mutations on HIV Replication and Transmission Cycles
Johnson, M. M., Jones, C. E., & Clark, D. N. (2022) · Viruses · doi:10.3390/v15010107 · Cited by 34
“The sequence of each domain from PDB files 1WJA [103], 1IHV [101], and 1BIS [104].”
MethodStructural Properties of HIV Integrase·Lens Epithelium-derived Growth Factor Oligomers
Gupta, K., Diamond, T. L., Hwang, Y. S., Bushman, F. D., & Duyne, G. D. V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.114413 · Cited by 25
Siwe‐Noundou, X., Musyoka, T. M., Moses, V., Ndinteh, D. T., Mnkandhla, D., Hoppe, H. C., Bishop, Ö. T., & Krause, R. W. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-41403-x · Cited by 27
Desfarges, S., Salin, B., Calmels, C., Andréola, M., Parissi, V., & Fournier, M. (2009) · Yeast · doi:10.1002/yea.1651 · Cited by 23
“This region is a dimer in solution (Lodi et al., 1995) with a structure very similar to the SH3 domain.”
BackgroundSolution Conformation and Dynamics of the HIV-1 Integrase Core Domain
Fitzkee, N. C., Masse, J. E., Shen, Y., Davies, D. R., & Bax, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.113407 · Cited by 29
Feiters, M. C., Eijkelenboom, A. P. A. M., Nolting, H., Krebs, B., van den Ent, F. M. I., Plasterk, R. H. A., Kaptein, R., & Boelens, R. (2002) · Journal of Synchrotron Radiation · doi:10.1107/s0909049502016205 · Cited by 24
“…years, structures of mutants of the catalytic core (X-ray crystallography; Dyda et al., 1994; Goldgur et al., 1998; Maignan et al., 1998; Greenwald et al., 1999) and of the C-terminal DNA binding domain (NMR; Eijkelenboom et al., 1995, 1999; Lodi et al., 1995) of HIV-1 integrase have been reported.”
BackgroundYi, J., Cheng, H., Andrake, M., Dunbrack, R. L., Röder, H., & Skalka, A. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105072200 · Cited by 24
Bischerour, J., Leh, H., Deprez, E., Brochon, J., & Mouscadet, J. F. (2002) · Journal of Virology · doi:10.1128/jvi.77.1.135-141.2003 · Cited by 25
Condensation of DNA by multivalent cations: Experimental studies of condensation kinetics
He, S., Arscott, P. G., & Bloomfield, V. A. (2000) · Biopolymers · doi:10.1002/(sici)1097-0282(20000405)53:4<329::aid-bip5>3.0.co;2-6 · Cited by 110
Natural selection results in conservation of HIV-1 integrase activity despite sequence variability
Reinke, R., Steffen, N. R., & Robinson, W. E. (2001) · AIDS · doi:10.1097/00002030-200105040-00002 · Cited by 21
“[20,21] and is believed to play a role in binding to host DNA.”
BackgroundGupta, K., Allen, A., Giraldo, C., Eilers, G., Sharp, R., Hwang, Y., Murali, H., Cruz, K., Janmey, P., Bushman, F., et al. (2021) · Structure · doi:10.1016/j.str.2020.12.001 · Cited by 19
Retroviral integrase protein and intasome nucleoprotein complex structures
Grawenhoff, J., & Engelman, A. (2017) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v8.i1.32 · Cited by 26
Self-citationModulation of the intrinsic chromatin binding property of HIV-1 integrase by LEDGF/p75
Lapaillerie, D., Lelandais, B., Mauro, E., Lagadec, F., Tumiotto, C., Miskey, C., Ferran, G., Kuschner, N., Calmels, C., Métifiot, M., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab886 · Cited by 23
“Interestingly, the carboxy-terminal domain (CTD) of HIV-1 IN (residues 220–270) displays a strong structural similarity to Tudor domains (10) which are known to bind histone tails (11,12).”
BackgroundMultivalent interactions essential for lentiviral integrase function
Ballandras-Colas, A., Chivukula, V., Gruszka, D. T., Shan, Z., Singh, P. K., Pye, V. E., McLean, R. K., Bedwell, G. J., Li, W., Nans, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29928-8 · Cited by 25
Self-citationComputer Tools in the Discovery of HIV-1 Integrase Inhibitors
Liao, C., & Nicklaus, M. C. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.193 · Cited by 21
The Drug-Induced Interface That Drives HIV-1 Integrase Hypermultimerization and Loss of Function
Singer, M. R., Dinh, T., Levintov, L., Annamalai, A. S., Rey, J. S., Briganti, L., Cook, N., Pye, V. E., Taylor, I. A., Kim, K., et al. (2023) · mBio · doi:10.1128/mbio.03560-22 · Cited by 21
“tion (36, 39) is crucial for the formation of higher-order lentiviral IN oligomers (40, 44).”
BackgroundSelf-citationNucleoprotein Intermediates in HIV-1 DNA Integration: Structure and Function of HIV-1 Intasomes
Craigie, R. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-10-8456-0_9 · Cited by 21
“(Figure 4B) 4.3 N-terminal domain structure The N-terminal domain structure was also determined by NMR (Cai et al. 1997).”
BackgroundSelf-citationMauro, E., Lesbats, P., Lapaillerie, D., Chaignepain, S., Maillot, B., Oladosu, O., Robert, X., Fiorini, F., Kieffer, B., Bouaziz, S., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz091 · Cited by 21
“The mapping of these missing residues on the 3D structure of the CTD published previously by other groups (28,29) shows that they are located in very flexible loops with the exception of the residue L242 located in the 2 strand.”
BackgroundIshikawa, T., Okui, N., Kobayashi, N., Sakuma, R., Kitamura, T., & Kitamura, Y. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4475-4480.1999 · Cited by 21
“The epitopes for MAbs 2-19 (from aa 228 to 236) and 6-19 (from aa 261 to 270) are likely to protrude outwards, whereas those for MAbs 8-22 (from aa 237 to 252) and 4-20 (from aa 253 to 261) form a homodimer interface (14, 29).”
BackgroundInfluentialAnti-HIV Agents: Current Status and Recent Trends
Geronikaki, A. A., Eleftheriou, P. T., & Poroikov, V. (2016) · Topics in medicinal chemistry · doi:10.1007/7355_2015_5001 · Cited by 17
Davids, B.-O., Balasubramaniam, M., Sapp, N., Prakash, P., Ingram, S., Li, M., Craigie, R., Hollis, T., Pandhare, J., & Dash, C. (2021) · Journal of Virology · doi:10.1128/jvi.00555-21 · Cited by 16
Self-citationRetroviral integrase: Structure, mechanism, and inhibition
Passos, D. O., Li, M., Craigie, R., & Lyumkis, D. (2021) · The Enzymes · doi:10.1016/bs.enz.2021.06.007 · Cited by 22
Self-citationThe C-Terminal Domain of HIV-1 Integrase: A Swiss Army Knife for the Virus?
Rocchi, C., Gouet, P., Parissi, V., & Fiorini, F. (2022) · Viruses · doi:10.3390/v14071397 · Cited by 19
“HIV-1 CTD dimer in solution (PDB: 1IHV; [33]).”
BackgroundInfluentialCalculation of Symmetric Oligomer Structures from NMR Data
O'Donoghue, S., & Nilges, M. (2002) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47084-5_4 · Cited by 17
Peptide inhibitors of HIV-1 integrase: From mechanistic studies to improved lead compounds
Maes, M., Levin, A., Hayouka, Z., Shalev, D. E., Loyter, A., & Friedler, A. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.09.053 · Cited by 17
The human interferon ? species and receptors
Pestka, S. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:4<254::aid-bip1001>3.0.co;2-1 · Cited by 157
Moreau, K., Faure, C., Verdier, G., & Ronfort, C. (2002) · Archives of Virology · doi:10.1007/s00705-002-0831-5 · Cited by 22
“The structure of the three domains have been determined by X-ray crystallography or nuclear magnetic resonance for IN of HIV-1 and shows that the three domains were found in dimeric forms [10, 17, 18, 19, 43 ].”
BackgroundMode of inhibition of HIV-1 Integrase by a C-terminal domain-specific monoclonal antibody*
Ramcharan, J., Colleluori, D. M., Merkel, G. W., Andrake, M., & Skalka, A. M. (2006) · Retrovirology · doi:10.1186/1742-4690-3-34 · Cited by 19
“The isolated CTD adopts an SH3 fold and forms a dimer in solution [19,20].”
BackgroundImpact of Resistance Mutations on Inhibitor Binding to HIV-1 Integrase
Chen, Q., Buolamwini, J. K., Smith, J. C., Li, A.-X., Xu, Q., Cheng, X., & Wei, D. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400537n · Cited by 22
Araújo, A. R., Ribeiro, A. J. M., Fernandes, P. A., & Ramos, M. J. (2014) · Journal of Chemical Theory and Computation · doi:10.1021/ct500570g · Cited by 16
Characterization of the Functional Domains of Human Foamy Virus Integrase Using Chimeric Integrases
Lee, H. S., Kang, S. Y., & Shin, C. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)13164-5 · Cited by 18
Yang, F., & Roth, M. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.20.9561-9570.2001 · Cited by 20
“4 bp 17 (53) 21 (66) 25 (73) 3 bp 3 (9) 1 (3) 3 (9) 5 bp 7 (22) 2 (6) 4 (12) Others 5 (16) 8 (25) 2 (6) Total 32 32 34”
Yang, F., León, Ó., Greenfield, N. J., & Roth, M. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1809-1817.1999 · Cited by 19
“the HIV-1 C terminus (20, 50), and the HHCC region (68)”
BackgroundWilliams, S., & Essex, J. W. (2009) · Journal of Chemical Theory and Computation · doi:10.1021/ct800162v · Cited by 16
Non-Enzymatic Functions of Retroviral Integrase: The Next Target for Novel Anti-HIV Drug Development
Masuda, T. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00210 · Cited by 22
“The CTD, consisting of a structure that closely resembles Src homology 3 domains (SH3-like), possesses sequence- and metal ion-independent DNA binding activity (Eijkelenboom et al., 1995; Lodi et al., 1995).”
BackgroundMass spectrometry-based footprinting of protein–protein interactions
McKee, C. J., Kessl, J. J., Norris, J. O., Shkriabai, N., & Kvaratskhelia, M. (2008) · Methods · doi:10.1016/j.ymeth.2008.10.023 · Cited by 20
Optimized binding of substituted quinoline ALLINIs within the HIV-1 integrase oligomer
Sun, J., Patel, K., Hume, J. D., Pigza, J. A., Donahue, M. G., & Kessl, J. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100363 · Cited by 14
Developing G-quartet oligonucleotides as novel anti-HIV agents: focus on anti-HIV drug design
Jing, N. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.8.1777 · Cited by 14
“The C-terminal domain can bind DNA non-specifically [44-46] and is composed of a five-stranded β-barrel with an SH3-like (Src-homology 3) fold [47,48].”
BackgroundDocking dinucleotides to HIV-1 integrase carboxyl-terminal domain to find possible DNA binding sites
Zhu, H. M., Chen, W. Z., & Wang, C. X. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.10.003 · Cited by 13
Metadata
- Authors
- Lodi, P. J., Ernst, J. A., Kuszewski, J., Hickman, A. B., Engelman, A., Craigie, R., Clore, G. M., & Gronenborn, A. M.
- Affiliations
- National Institutes of Health (US)
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1995-08-08
- Volume
- 34
- Issue
- 31
- Pages
- 9826-9833
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2140854337
- Cited by
- 300
- References
- 41
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 8 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 3 · 2015: 7 · 2014: 8 · 2013: 10 · 2012: 10
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- HIV-1 integrase, DNA-binding domain, solution structure, protein dimer, DNA binding sites, lysine residues, antiparallel beta-sheet
- MeSH terms
- Amino Acid Sequence, Binding Sites, DNA Nucleotidyltransferases, DNA-Binding Proteins, Escherichia coli, Models, Molecular, Molecular Sequence Data, Magnetic Resonance Spectroscopy, Peptide Fragments, Protein Conformation, Proteins, Recombinant Proteins, Solutions, Spectrin, HIV-1, Sequence Homology, Integrases, Adaptor Proteins, Signal Transducing, GRB2 Adaptor Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.